Litcius/Paper detail

Tumor-related HSP70 released after cryo-thermal therapy targeted innate immune initiation in the antitumor immune response

Jun Zhu, Yue Lou, Ping Liu, Lisa X. Xu

2020International Journal of Hyperthermia31 citationsDOIOpen Access PDF

Abstract

PURPOSE: Th1 cell-dominated antitumor response was developed. However, why cryo-thermal therapy can induce the maturation of innate immunity remains unknown. METHODS: . The phenotypic and functional changes in MDSCs, DCs and macrophages were analyzed using FACS and qRT-PCR. An anti-HSP70 antibody was injected intravenously at 6 h after cryo-thermal therapy on days 1 and 2 and mouse survival was monitored. RESULTS: neutralization of HSP70 in the early stage of treatment could significantly decrease the survival rate of cryo-thermal therapy treated mice. CONCLUSIONS: Local cryo-thermal therapy not only destroyed solid tumors thermally and mechanically but also induced the release of a large amount of DAMPs to effectively trigger a systemic antitumor response.

Topics & Concepts

CalreticulinInnate immune systemHsp70Immune systemHeat shock proteinMacrophage polarizationIn vivoCancer researchDownregulation and upregulationImmunogenic cell deathAntibodyMacrophageImmunologyBiologyImmunotherapyIn vitroCell biologyEndoplasmic reticulumBiotechnologyBiochemistryGeneHeat shock proteins researchToxin Mechanisms and ImmunotoxinsThermal properties of materials
Tumor-related HSP70 released after cryo-thermal therapy targeted innate immune initiation in the antitumor immune response | Litcius